Stocktoria

Medinotec Inc. MDNC

OTC · OOTC · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2023-03-21

Medinotec Inc. (MDNC) earns a Piotroski F-score of 5/9 (mixed financial health). It does not currently pay a dividend. FY2026 revenue was $9.7M at a 8.2% net margin.

5/9
Piotroski F — financial health
Altman Z″ — distress risk
Dividend payout · no dividend
$5.00 as of 2026-06-01 · +0% 1y

Price from month-end closes (Yahoo) — for reference, not real-time.

P / E74×
Net margin8.2%
Revenue trend · last 4y · up

How it ranks in Manufacturing · percentile among 1829 companies

Piotroski Fstronger than 62%
Net marginstronger than 75%
Return on equitystronger than 81%

Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 5/9 tests passed

Detailed pages

Sector peers · similar-size Manufacturing companies

TickerCompanyPiotroski FAltman Z″P / ERevenue growth
MDNCMedinotec Inc.5/974
WOKWORK Medical Technology Group LTD4/9-14.4%
NMTCNEUROONE MEDICAL TECHNOLOGIES Corp5/9-19.57
NSPRInspireMD, Inc.3/9-10.12
NXGLNEXGEL, INC.5/9-6.91
XAIRBeyond Air, Inc.5/9
IVFINVO Fertility, Inc.4/9-19.01

All Manufacturing companies →

FAQ

Is MDNC financially healthy?

Medinotec Inc.'s Piotroski F-score is 5/9 (8–9 is excellent, 0–3 weak).

Does MDNC pay a dividend?

No, Medinotec Inc. does not currently pay a dividend.

How profitable is MDNC?

In FY2026, Medinotec Inc. had a net margin of 8.2% and a return on equity of 13.9%.

Source: SEC EDGAR filings · CIK 0001931055 · as of 2026-02-28. Facts from filings plus Stocktoria's own computed scores — not investment advice.